Immunobiology of Cancer
Trial ID or NCT#
NCT00767533
Status
NOT RECRUITING
Purpose
To learn whether or not an Interferon defect in cell signaling, recently discovered in immune cells from melanoma patients as well as breast cancer patients, is common to all cancers.
Official Title
Immunobiology of Cancer
Contact us to find out if this trial is right for you.
Contact
ccto-office@stanford.edu
650-498-7061
View on ClinicalTrials.gov
